Tsatsou Ioanna, Parpa Efi, Nikoloudi Maria, Kalogeridi Maria-Aggeliki, Keramida Euaggelia, Galanos Antonis, Mystakidou Kyriaki
One Day Clinic, Hellenic Airforce General Hospital, Athens, Greece.
Pain Relief and Palliative Care Unit, Department of Radiology, Areteion Hospital, School of Medicine, National & Kapodistrian University of Athens, Athens, Greece.
J Caring Sci. 2024 Jun 1;13(3):158-166. doi: 10.34172/jcs.33228. eCollection 2024 Oct.
In palliative care, assessing outcomes and evaluating quality of life (QoL) are essential to ensure high-quality, evidence-based care. The aim of this study was the Greek validation of the Functional Assessment Chronic Illness Therapy-Palliative Care (FACIT-PAL-14) in patients with cancer.
The FACIT-PAL-14 was translated into Greek and administered to 185 patients with cancer treated in two central hospitals of Athens, Greece. Data collection lasted from January to March 2022. FACIT-PAL-14 is a 41 item measurement of QoL that includes the 27 items of the FACIT-General and 14 additional items that form the palliative care scale. The Monroe Dunaway Anderson Symptom Inventory (MDASI), was used to evaluate the criterion validity. Also the following analyses were conducted; confirmatory factor analysis (CFA), exploratory factor analysis (EFA), concurrent validity, internal consistency and instrument stability.
Participants' mean (SD) age was 57.37(14.38) and the majority were women (55.1%) and had breast cancer (31.4%). Three factors were exported from the statistical analysis of the palliative care scale that explained the 62.21% of the variance. Τhese factors were psychological wellbeing, physical symptoms and close relationships. FACIT-PAL-14 and its factors had high internal consistency. Cronbach's alpha coefficient for the total score of the FACIT-PAL-14 questionnaire was 0.781. Intraclass correlation (ICC) between initial assessment and reassessment of the FACIT-PAL-14 factor 1, factor 2, factor 3 and total score were 0.985, 0.972, 0.981 and 0.991 respectively. FACIT-PAL-14 subscales presented moderate correlation with MDASI subscales.
The Greek version of FACIT-PAL-14 is valid and reliable scale in patients with cancer.
在姑息治疗中，评估结果和评价生活质量（QoL）对于确保高质量的循证护理至关重要。本研究的目的是对癌症患者进行功能性评估慢性病治疗-姑息治疗（FACIT-PAL-14）量表的希腊语验证。
将FACIT-PAL-14翻译成希腊语，并应用于希腊雅典两家中心医院接受治疗的185例癌症患者。数据收集时间为2022年1月至3月。FACIT-PAL-14是一项包含41个条目的生活质量测量工具，其中包括FACIT-通用量表的27个条目以及构成姑息治疗量表的另外14个条目。使用门罗·邓纳韦·安德森症状量表（MDASI）来评估效标效度。此外，还进行了以下分析：验证性因素分析（CFA）、探索性因素分析（EFA）、同时效度、内部一致性和工具稳定性分析。
参与者的平均（标准差）年龄为57.37（14.38）岁，大多数为女性（55.1%），患有乳腺癌的患者占31.4%。从姑息治疗量表的统计分析中得出三个因素，这三个因素解释了62.21%的方差。这些因素分别是心理健康、身体症状和亲密关系。FACIT-PAL-14及其各因素具有较高的内部一致性。FACIT-PAL-14问卷总分的克朗巴哈α系数为0.781。FACIT-PAL-14因素1、因素2、因素3和总分在初次评估和重新评估之间的组内相关系数（ICC）分别为0.985、0.972、0.981和0.991。FACIT-PAL-14分量表与MDASI分量表呈中度相关。
FACIT-PAL-14希腊语版本在癌症患者中是一个有效且可靠的量表。
